During the forecast period 2023 to 2033, the Cerebral vein thrombosis treatment market is expected to grow at a value of 12.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Cerebral vein thrombosis treatment is expected to rise up to a market valuation of US$ 611 million. Growth of the market can be attributed to advances in medical technologies, increasing prevalence of CVT, and rising healthcare expenditure.
The increasing prevalence of CVT, especially among younger individuals, is a significant driver of this growth. According to the National Institute of Neurological Disorders and Stroke (NINDS), CVT affects between 3 and 4 individuals per million each year, with higher incidence rates reported in women and individuals under the age of 50.
Empower your decisions with data-driven insights from our Sample Report – Get It Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16977
Another key factor driving the growth of the CVT treatment market is the availability of advanced medical technologies. Technological advancements in medical devices and procedures, such as catheter-based therapies and imaging techniques, have improved the accuracy and efficacy of CVT treatment. For instance, endovascular therapy, which involves the use of catheter-based techniques to remove blood clots from the cerebral veins, has shown promising results in the treatment of CVT.
Furthermore, the increasing investment in research and development activities by key players in the market is creating new opportunities for growth. Companies such as Boston Scientific Corporation, AngioDynamics, and Cardinal Health are actively involved in the development of innovative treatment options for CVT, such as thrombectomy devices and drug therapies.
Key Takeaways from the Market Study:
- The global Cerebral vein thrombosis treatment market is expected to grow with a 12.3% CAGR during 2023 to 2033.
- By end use, hospitals and clinics are expected to hold 46% of the market share in 2023 for Cerebral vein thrombosis treatment market.
- North America is expected to possess 44% market share for Cerebral vein thrombosis treatment market in 2023.
- Europe Cerebral vein thrombosis treatment market size is expected to possess 41% market share in 2023.
“Availability of effective and safe drug therapies is expected to drive the growth of the CVT treatment market in the upcoming years.” states an FMI analyst
Our Analyst Is Available To Help You With Any Inquiries Reach Out Anytime! https://www.futuremarketinsights.com/ask-question/rep-gb-16977
Competitive Landscape:
Key players in the cerebral vein thrombosis treatment market are Boston Scientific Corporation, AngioDynamics, Cardinal Health, Daesung Maref, Johnson & Johnson Services, Inc., Neuland Laboratories Ltd, Glenmark Pharmaceuticals Inc., Momenta Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation and Portola Pharmaceuticals, Inc.
- Boston Scientific Corporation is involved in clinical research related to CVT. The company has conducted clinical trials to evaluate the safety and efficacy of its Vici Venous Stent System in the treatment of deep vein obstruction.
- AngioDynamics’ key product for CVT treatment is BioFlo PICC, which is a peripherally inserted central catheter (PICC) that is coated with a proprietary Endexo technology. This coating has been shown to reduce the risk of catheter-related thrombosis, which can be a complication of CVT.
Key Segments Profiled in the Cerebral Vein Thrombosis Treatment Industry Survey:
Treatment:
- Thrombolytic Therapy
- Anticonvulsant Therapy
Drug Class:
- Thalidomide
- Tamoxifen
- Phytoestrogens
- L-asparaginase
End Use:
- Hospitals & Clinics
- Laboratories
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Elevate Your Brand: Explore the Insights from Our Customization Report! https://www.futuremarketinsights.com/customization-available/rep-gb-16977
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube